Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [5451]

Concomitant use of antibiotics and immune checkpoint inhibitors in patients...

Dr Akhil Kapoor - Tata Memorial Center, Mumbai, India

Concomitant use of antibiotics and immune checkpoint inhibitors in patients with solid neoplasms ( Dr Akhil Kapoor - Tata Memorial Center, Mumbai, India )

COVID-19: Management of non-small cell lung cancer patients during the...

Dr Heather Wakelee - Stanford University, Stanford, USA

COVID-19: Management of non-small cell lung cancer patients during the coronavirus pandemic ( Dr Heather Wakelee - Stanford University, Stanford, USA )

Prostate cancer patients receiving androgen-deprivation therapies shown to be...

Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona...

Prostate cancer patients receiving androgen-deprivation therapies shown to be at lower risk from COVID-19 ( Prof Andrea Alimonti - Università della Svizzera Italiana, Bellinzona, Switzerland )

Managing toxicities associated with immune-checkpoint inhibitors

Prof Olivier Lambotte - Hôpitaux de Paris, Paris, France

Managing toxicities associated with immune-checkpoint inhibitors ( Prof Olivier Lambotte - Hôpitaux de Paris, Paris, France )

I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk...

Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA

I-SPY 2: Durvalumab in combination with olaparib and paclitaxel in high-risk HER2 negative stage II/III breast cancer ( Prof Lajos Pusztai - Yale Cancer Center, New Haven, USA )

COVID-19: Managing paediatric patients under the COVID pandemic

Dr Carmen Ballestas - Memorial Healthcare System, Florida, Miami

COVID-19: Managing paediatric patients under the COVID pandemic ( Dr Carmen Ballestas - Memorial Healthcare System, Florida, Miami )

Meet the Expert: Dr Bodour Salhia

Dr Bodour Salhia - University of Southern California, Los Angeles, USA

Meet the Expert: Dr Bodour Salhia ( Dr Bodour Salhia - University of Southern California, Los Angeles, USA )

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients...

Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia

IMspire 150: Atezolizumab, cobimetinib and vemurafenib in untreated patients with BRAFV600 mutation-positive advanced melanoma ( Prof Grant McArthur - Peter MacCallum Cancer Center, Melbourne, Australia )

Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated...

Prof Alain Algazi -University of California San Francisco, San Francisco, USA

Continuous vs intermittent dosing of dabrafenib and trametinib in BRAF mutated melanoma ( Prof Alain Algazi -University of California San Francisco, San Francisco, USA )

An oncologist's experience of managing breast cancer during the COVID-19...

Prof Alessandra Gennari - University Hospital of Novara, Piedmont, Italy

An oncologist's experience of managing breast cancer during the COVID-19 outbreak ( Prof Alessandra Gennari - University Hospital of Novara, Piedmont, Italy )

COVID-19: What can be learned from Australia's approach

Prof Eva Segelov - Monash University, Melbourne, Australia

COVID-19: What can be learned from Australia's approach ( Prof Eva Segelov - Monash University, Melbourne, Australia )

New oncogenic drivers in NSCLC

Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands

New oncogenic drivers in NSCLC ( Prof Egbert Smit - Netherlands Cancer Institute, Amsterdam, Netherlands )

More from ecancer